| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 9.68e-10 | 70 | 56 | 7 | GO:1901618 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 1.93e-09 | 7 | 56 | 4 | GO:0005412 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 4.68e-09 | 23 | 56 | 5 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 1.63e-08 | 29 | 56 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 3.78e-08 | 34 | 56 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 5.44e-08 | 14 | 56 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC5A11 STIM1 SLC5A10 CEACAM5 CFTR COX6B1 CEACAM7 CEACAM8 COX7B GABRQ CEACAM6 PKD1L2 ZDHHC13 CEACAM1 SLC5A2 SLC5A3 | 8.81e-08 | 1180 | 56 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 1.28e-07 | 17 | 56 | 4 | GO:0005402 | |
| GeneOntologyMolecularFunction | glycolipid binding | 2.51e-07 | 49 | 56 | 5 | GO:0051861 | |
| GeneOntologyMolecularFunction | transporter activity | SLC5A11 STIM1 SLC5A10 CEACAM5 CFTR COX6B1 CEACAM7 CEACAM8 COX7B GABRQ CEACAM6 PKD1L2 ZDHHC13 CEACAM1 SLC5A2 SLC5A3 | 2.94e-07 | 1289 | 56 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 6.72e-07 | 25 | 56 | 4 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 6.72e-07 | 25 | 56 | 4 | GO:0015149 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 9.28e-07 | 27 | 56 | 4 | GO:0015145 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.25e-06 | 29 | 56 | 4 | GO:0051119 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.25e-06 | 29 | 56 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.88e-06 | 73 | 56 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.93e-06 | 210 | 56 | 7 | GO:0019903 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 5.30e-06 | 90 | 56 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 5.74e-06 | 42 | 56 | 4 | GO:0015144 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC5A11 STIM1 SLC5A10 CFTR COX6B1 COX7B GABRQ PKD1L2 ZDHHC13 SLC5A2 SLC5A3 | 6.86e-06 | 758 | 56 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 7.73e-06 | 2 | 56 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | phosphatase binding | 8.70e-06 | 264 | 56 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC5A11 STIM1 SLC5A10 CFTR COX6B1 COX7B GABRQ PKD1L2 ZDHHC13 SLC5A2 SLC5A3 | 1.05e-05 | 793 | 56 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | myo-inositol transmembrane transporter activity | 4.62e-05 | 4 | 56 | 2 | GO:0005365 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC5A11 STIM1 SLC5A10 COX6B1 COX7B PKD1L2 ZDHHC13 SLC5A2 SLC5A3 | 5.68e-05 | 627 | 56 | 9 | GO:0022890 |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 6.08e-05 | 149 | 56 | 5 | GO:1990782 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 7.68e-05 | 5 | 56 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 7.86e-05 | 81 | 56 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC5A11 STIM1 SLC5A10 COX6B1 COX7B PKD1L2 ZDHHC13 SLC5A2 SLC5A3 | 8.81e-05 | 664 | 56 | 9 | GO:0008324 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 1.19e-04 | 398 | 56 | 7 | GO:0046982 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 1.23e-04 | 173 | 56 | 5 | GO:0070851 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.52e-04 | 37 | 56 | 3 | GO:0004190 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 1.61e-04 | 7 | 56 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.64e-04 | 38 | 56 | 3 | GO:0070001 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.66e-04 | 293 | 56 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.92e-04 | 301 | 56 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.20e-04 | 196 | 56 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 2.50e-04 | 316 | 56 | 6 | GO:0035091 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.84e-04 | 207 | 56 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.90e-04 | 208 | 56 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.07e-04 | 465 | 56 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.47e-04 | 119 | 56 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 3.58e-04 | 477 | 56 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.60e-04 | 230 | 56 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | polyol transmembrane transporter activity | 5.91e-04 | 13 | 56 | 2 | GO:0015166 | |
| GeneOntologyMolecularFunction | glucosidase activity | 7.92e-04 | 15 | 56 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | symporter activity | 8.30e-04 | 150 | 56 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | cytochrome-c oxidase activity | 9.04e-04 | 16 | 56 | 2 | GO:0004129 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.15e-03 | 18 | 56 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a heme group of donors | 1.15e-03 | 18 | 56 | 2 | GO:0016675 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.35e-03 | 171 | 56 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 2.12e-03 | 324 | 56 | 5 | GO:0005126 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.79e-03 | 28 | 56 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 3.03e-03 | 103 | 56 | 3 | GO:0004553 | |
| GeneOntologyMolecularFunction | phospholipid binding | 4.22e-03 | 548 | 56 | 6 | GO:0005543 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 4.83e-03 | 37 | 56 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | protein dimerization activity | GHR IL12B CEACAM5 PRMT5 CEACAM7 CEACAM8 CEACAM6 CST7 CEACAM1 | 6.00e-03 | 1205 | 56 | 9 | GO:0046983 |
| GeneOntologyMolecularFunction | endopeptidase activity | 7.02e-03 | 430 | 56 | 5 | GO:0004175 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 7.49e-03 | 815 | 56 | 7 | GO:0042803 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 7.70e-03 | 144 | 56 | 3 | GO:0016798 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 8.68e-03 | 50 | 56 | 2 | GO:0099095 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 9.50e-03 | 296 | 56 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | cytokine binding | 9.75e-03 | 157 | 56 | 3 | GO:0019955 | |
| GeneOntologyMolecularFunction | peptidase activity | 9.77e-03 | 654 | 56 | 6 | GO:0008233 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 1.06e-02 | 162 | 56 | 3 | GO:0099106 | |
| GeneOntologyMolecularFunction | protein kinase binding | 1.07e-02 | 873 | 56 | 7 | GO:0019901 | |
| GeneOntologyMolecularFunction | actin binding | 1.09e-02 | 479 | 56 | 5 | GO:0003779 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.11e-02 | 310 | 56 | 4 | GO:0030246 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 2.20e-10 | 14 | 55 | 5 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 3.29e-10 | 15 | 55 | 5 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 3.29e-10 | 15 | 55 | 5 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 4.78e-10 | 16 | 55 | 5 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 6.76e-10 | 17 | 55 | 5 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 6.76e-10 | 17 | 55 | 5 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 9.34e-10 | 18 | 55 | 5 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.68e-09 | 20 | 55 | 5 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 2.20e-09 | 21 | 55 | 5 | GO:0070345 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.63e-09 | 23 | 55 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 4.58e-09 | 24 | 55 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 4.58e-09 | 24 | 55 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 5.71e-09 | 25 | 55 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 8.64e-09 | 27 | 55 | 5 | GO:0070344 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 2.13e-08 | 32 | 55 | 5 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 2.51e-08 | 33 | 55 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 3.42e-08 | 35 | 55 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 5.25e-08 | 38 | 55 | 5 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 6.01e-08 | 39 | 55 | 5 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 6.04e-08 | 15 | 55 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.04e-08 | 15 | 55 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.05e-07 | 17 | 55 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.26e-07 | 45 | 55 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.41e-07 | 46 | 55 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.41e-07 | 46 | 55 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.58e-07 | 47 | 55 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.95e-07 | 49 | 55 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.95e-07 | 49 | 55 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 2.16e-07 | 50 | 55 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 2.62e-07 | 21 | 55 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 2.62e-07 | 21 | 55 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 3.19e-07 | 22 | 55 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 3.85e-07 | 56 | 55 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.86e-07 | 23 | 55 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 4.62e-07 | 24 | 55 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 5.47e-07 | 60 | 55 | 5 | GO:0045922 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 5.49e-07 | 25 | 55 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 5.94e-07 | 61 | 55 | 5 | GO:0060259 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 8.83e-07 | 28 | 55 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.02e-06 | 29 | 55 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 1.15e-06 | 128 | 55 | 6 | GO:0050795 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 1.15e-06 | 128 | 55 | 6 | GO:0034103 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.19e-06 | 70 | 55 | 5 | GO:0045124 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.27e-06 | 71 | 55 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.35e-06 | 31 | 55 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 1.37e-06 | 72 | 55 | 5 | GO:0032692 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 1.46e-06 | 73 | 55 | 5 | GO:0042304 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.54e-06 | 32 | 55 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.54e-06 | 32 | 55 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.75e-06 | 33 | 55 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.79e-06 | 76 | 55 | 5 | GO:0042269 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.98e-06 | 34 | 55 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.98e-06 | 34 | 55 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 2.31e-06 | 80 | 55 | 5 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 2.31e-06 | 80 | 55 | 5 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 3.31e-06 | 86 | 55 | 5 | GO:0042058 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 3.85e-06 | 40 | 55 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of defense response | 4.11e-06 | 353 | 55 | 8 | GO:0031348 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 4.26e-06 | 41 | 55 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 4.37e-06 | 91 | 55 | 5 | GO:0051055 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 4.55e-06 | 358 | 55 | 8 | GO:0015850 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 4.70e-06 | 42 | 55 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 4.87e-06 | 93 | 55 | 5 | GO:1901184 | |
| GeneOntologyBiologicalProcess | bone resorption | 6.62e-06 | 99 | 55 | 5 | GO:0045453 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 7.41e-06 | 271 | 55 | 7 | GO:0032869 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 7.41e-06 | 47 | 55 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 7.41e-06 | 47 | 55 | 4 | GO:0034104 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 8.83e-06 | 105 | 55 | 5 | GO:0042267 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 1.06e-05 | 109 | 55 | 5 | GO:0002228 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.11e-05 | 52 | 55 | 4 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.20e-05 | 53 | 55 | 4 | GO:0034110 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 1.43e-05 | 116 | 55 | 5 | GO:0045670 | |
| GeneOntologyBiologicalProcess | liver development | 1.59e-05 | 202 | 55 | 6 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 1.73e-05 | 205 | 55 | 6 | GO:0061008 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.85e-05 | 59 | 55 | 4 | GO:0045671 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | GHR STIM1 IL12B NPTX1 NAMPT CEACAM5 PRMT5 CFTR CEACAM7 CEACAM8 CEACAM6 TNFRSF1B PTGER4 CEACAM1 | 1.91e-05 | 1450 | 55 | 14 | GO:1901701 |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 1.97e-05 | 60 | 55 | 4 | GO:0030851 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.98e-05 | 124 | 55 | 5 | GO:0001910 | |
| GeneOntologyBiologicalProcess | bone remodeling | 2.22e-05 | 127 | 55 | 5 | GO:0046849 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 2.40e-05 | 129 | 55 | 5 | GO:0043406 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | GHR STIM1 NAMPT CEACAM5 PRMT5 CFTR CEACAM7 CEACAM8 CEACAM6 CEACAM1 | 2.59e-05 | 752 | 55 | 10 | GO:1901699 |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 2.88e-05 | 134 | 55 | 5 | GO:0019217 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 2.88e-05 | 66 | 55 | 4 | GO:0010543 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | 3.00e-05 | 226 | 55 | 6 | GO:0050680 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 3.06e-05 | 67 | 55 | 4 | GO:0045601 | |
| GeneOntologyBiologicalProcess | response to insulin | 3.32e-05 | 342 | 55 | 7 | GO:0032868 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 3.43e-05 | 139 | 55 | 5 | GO:0007173 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 3.44e-05 | 69 | 55 | 4 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 3.47e-05 | 232 | 55 | 6 | GO:0002706 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 3.64e-05 | 70 | 55 | 4 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of T cell proliferation | 3.82e-05 | 236 | 55 | 6 | GO:0042129 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 3.85e-05 | 350 | 55 | 7 | GO:0045860 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 3.85e-05 | 71 | 55 | 4 | GO:0043114 | |
| GeneOntologyBiologicalProcess | energy homeostasis | 4.06e-05 | 144 | 55 | 5 | GO:0097009 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 4.07e-05 | 72 | 55 | 4 | GO:0050819 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 4.20e-05 | 145 | 55 | 5 | GO:0045833 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 4.48e-05 | 147 | 55 | 5 | GO:0031341 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 4.78e-05 | 149 | 55 | 5 | GO:0062014 | |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | 5.72e-05 | 509 | 55 | 8 | GO:0032102 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | STIM1 SLC5A10 CLEC4A CFTR COX6B1 COX7B GABRQ PKD1L2 ZDHHC13 SLC5A2 SLC5A3 | 6.44e-05 | 1017 | 55 | 11 | GO:0098660 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 4.91e-10 | 16 | 56 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | apical part of cell | SLC5A11 MGAM SLC5A10 CEACAM5 CFTR CEACAM7 CEACAM8 BYSL CEACAM6 USH2A CEACAM1 SLC5A2 SLC5A3 | 4.09e-09 | 592 | 56 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC5A11 MGAM SLC5A10 CEACAM5 CFTR CEACAM7 CEACAM8 CEACAM6 USH2A CEACAM1 SLC5A2 SLC5A3 | 4.92e-09 | 487 | 56 | 12 | GO:0016324 |
| GeneOntologyCellularComponent | late endosome lumen | 1.50e-08 | 11 | 56 | 4 | GO:0031906 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 6.33e-07 | 7 | 56 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 2.07e-06 | 320 | 56 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | receptor complex | GHR IL12B CEACAM5 CEACAM7 CEACAM8 GABRQ CEACAM6 DLG3 TNFRSF1B CEACAM1 | 2.87e-06 | 581 | 56 | 10 | GO:0043235 |
| GeneOntologyCellularComponent | lateral plasma membrane | 4.25e-06 | 90 | 56 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | basal plasma membrane | 4.37e-06 | 354 | 56 | 8 | GO:0009925 | |
| GeneOntologyCellularComponent | endosome lumen | 5.27e-06 | 43 | 56 | 4 | GO:0031904 | |
| GeneOntologyCellularComponent | basal part of cell | 7.07e-06 | 378 | 56 | 8 | GO:0045178 | |
| GeneOntologyCellularComponent | adherens junction | 2.16e-05 | 212 | 56 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | late endosome | 3.84e-05 | 348 | 56 | 7 | GO:0005770 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 6.29e-05 | 157 | 56 | 5 | GO:1902554 | |
| GeneOntologyCellularComponent | T cell receptor complex | 7.51e-05 | 163 | 56 | 5 | GO:0042101 | |
| GeneOntologyCellularComponent | multivesicular body | 9.11e-05 | 88 | 56 | 4 | GO:0005771 | |
| GeneOntologyCellularComponent | protein kinase complex | 9.16e-05 | 170 | 56 | 5 | GO:1902911 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.38e-04 | 98 | 56 | 4 | GO:0060170 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 3.39e-04 | 350 | 56 | 6 | GO:0098802 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 4.52e-04 | 519 | 56 | 7 | GO:0009897 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 9.92e-04 | 73 | 56 | 3 | GO:0070821 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.01e-03 | 431 | 56 | 6 | GO:0031253 | |
| GeneOntologyCellularComponent | membrane protein complex | CEACAM5 CFTR COX6B1 CEACAM7 CEACAM8 COX7B GABRQ CEACAM6 DLG3 CEACAM1 SLC5A3 | 1.83e-03 | 1498 | 56 | 11 | GO:0098796 |
| GeneOntologyCellularComponent | secretory granule membrane | 1.86e-03 | 329 | 56 | 5 | GO:0030667 | |
| GeneOntologyCellularComponent | specific granule membrane | 1.87e-03 | 91 | 56 | 3 | GO:0035579 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 2.01e-03 | 335 | 56 | 5 | GO:0061695 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.03e-03 | 25 | 56 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | side of membrane | 2.18e-03 | 875 | 56 | 8 | GO:0098552 | |
| GeneOntologyCellularComponent | cell surface | GHR IL12B CEACAM5 CLEC4A CFTR CEACAM7 CEACAM8 CEACAM6 CEACAM1 | 2.60e-03 | 1111 | 56 | 9 | GO:0009986 |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.68e-03 | 523 | 56 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | respiratory chain complex IV | 2.92e-03 | 30 | 56 | 2 | GO:0045277 | |
| GeneOntologyCellularComponent | transporter complex | 3.44e-03 | 550 | 56 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 4.80e-03 | 785 | 56 | 7 | GO:0098797 | |
| GeneOntologyCellularComponent | cell-cell junction | 4.88e-03 | 591 | 56 | 6 | GO:0005911 | |
| GeneOntologyCellularComponent | cytochrome complex | 6.20e-03 | 44 | 56 | 2 | GO:0070069 | |
| MousePheno | increased abdominal fat pad weight | 1.43e-10 | 27 | 42 | 6 | MP:0009286 | |
| MousePheno | increased skeletal muscle triglyceride level | 3.76e-09 | 21 | 42 | 5 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 7.80e-09 | 24 | 42 | 5 | MP:0014172 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 3.07e-08 | 31 | 42 | 5 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 3.07e-08 | 31 | 42 | 5 | MP:0008964 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 5.81e-08 | 35 | 42 | 5 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 6.74e-08 | 36 | 42 | 5 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 1.02e-07 | 39 | 42 | 5 | MP:0030022 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.63e-07 | 17 | 42 | 4 | MP:0031047 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 2.68e-07 | 47 | 42 | 5 | MP:0031617 | |
| MousePheno | decreased cellular glucose uptake | 4.94e-07 | 53 | 42 | 5 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 5.43e-07 | 54 | 42 | 5 | MP:0010953 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 9.26e-07 | 60 | 42 | 5 | MP:0009790 | |
| MousePheno | abnormal lipid oxidation | 1.01e-06 | 61 | 42 | 5 | MP:0010951 | |
| MousePheno | obese | 1.01e-06 | 113 | 42 | 6 | MP:0001261 | |
| MousePheno | increased insulin secretion | 1.28e-06 | 64 | 42 | 5 | MP:0003058 | |
| MousePheno | increased food intake | 1.34e-06 | 189 | 42 | 7 | MP:0011939 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 1.37e-06 | 28 | 42 | 4 | MP:0020950 | |
| MousePheno | abnormal muscle cell glucose uptake | 1.61e-06 | 67 | 42 | 5 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 1.61e-06 | 67 | 42 | 5 | MP:0008962 | |
| MousePheno | abnormal circulating insulin level | GHR STIM1 MGAM SLC5A10 CEACAM5 CEACAM7 CEACAM8 CEACAM6 CEACAM1 SLC5A2 | 1.80e-06 | 505 | 42 | 10 | MP:0001560 |
| MousePheno | increased circulating leptin level | 1.83e-06 | 125 | 42 | 6 | MP:0005669 | |
| MousePheno | abnormal pancreas physiology | 2.10e-06 | 292 | 42 | 8 | MP:0002693 | |
| MousePheno | decreased oxygen consumption | 3.66e-06 | 79 | 42 | 5 | MP:0005290 | |
| MousePheno | polyphagia | 3.90e-06 | 80 | 42 | 5 | MP:0001433 | |
| MousePheno | abnormal glycogen homeostasis | 4.16e-06 | 144 | 42 | 6 | MP:0005438 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 8.76e-06 | 44 | 42 | 4 | MP:0031023 | |
| MousePheno | abnormal endocrine gland physiology | 1.04e-05 | 363 | 42 | 8 | MP:0013561 | |
| MousePheno | abnormal insulin secretion | 1.12e-05 | 171 | 42 | 6 | MP:0003564 | |
| MousePheno | abnormal abdominal fat pad morphology | 1.15e-05 | 262 | 42 | 7 | MP:0000010 | |
| MousePheno | abnormal cellular glucose uptake | 1.29e-05 | 102 | 42 | 5 | MP:0003925 | |
| MousePheno | abnormal endocrine pancreas secretion | 1.32e-05 | 176 | 42 | 6 | MP:0014195 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.35e-05 | 49 | 42 | 4 | MP:0020948 | |
| MousePheno | decreased circulating triglyceride level | 1.58e-05 | 275 | 42 | 7 | MP:0002644 | |
| MousePheno | abnormal pancreas secretion | 1.64e-05 | 183 | 42 | 6 | MP:0002694 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 1.74e-05 | 279 | 42 | 7 | MP:0009785 | |
| MousePheno | decreased respiratory quotient | 1.86e-05 | 110 | 42 | 5 | MP:0010379 | |
| MousePheno | increased circulating insulin level | 1.90e-05 | 283 | 42 | 7 | MP:0002079 | |
| MousePheno | abnormal pancreatic beta cell physiology | 2.43e-05 | 196 | 42 | 6 | MP:0003562 | |
| MousePheno | decreased energy expenditure | 2.72e-05 | 119 | 42 | 5 | MP:0004890 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 2.83e-05 | 120 | 42 | 5 | MP:0009786 | |
| MousePheno | abnormal gland physiology | GHR NAMPT CEACAM5 CLEC4A CFTR CEACAM7 CEACAM8 CEACAM6 TNFRSF1B CEACAM1 | 2.85e-05 | 691 | 42 | 10 | MP:0002164 |
| MousePheno | abnormal endocrine pancreas physiology | 2.87e-05 | 202 | 42 | 6 | MP:0010147 | |
| MousePheno | decreased susceptibility to viral infection | 3.44e-05 | 125 | 42 | 5 | MP:0002410 | |
| MousePheno | abnormal fat pad morphology | 3.71e-05 | 314 | 42 | 7 | MP:0005334 | |
| MousePheno | abnormal vascular wound healing | 6.59e-05 | 73 | 42 | 4 | MP:0004883 | |
| MousePheno | abnormal circulating leptin level | 6.85e-05 | 236 | 42 | 6 | MP:0005667 | |
| MousePheno | decreased triglyceride level | 7.11e-05 | 348 | 42 | 7 | MP:0005318 | |
| MousePheno | impaired glucose tolerance | 7.69e-05 | 480 | 42 | 8 | MP:0005293 | |
| MousePheno | abnormal food intake | 7.80e-05 | 481 | 42 | 8 | MP:0005449 | |
| MousePheno | abnormal glucose tolerance | STIM1 IL12B NAMPT CEACAM5 SWT1 CEACAM7 CEACAM8 CEACAM6 CEACAM1 SLC5A2 | 8.57e-05 | 787 | 42 | 10 | MP:0005291 |
| MousePheno | abnormal colon morphology | 8.75e-05 | 152 | 42 | 5 | MP:0000495 | |
| MousePheno | increased total tissue mass | 9.42e-05 | 364 | 42 | 7 | MP:0012323 | |
| MousePheno | increased body weight | 9.42e-05 | 364 | 42 | 7 | MP:0001260 | |
| MousePheno | decreased susceptibility to Riboviria infection | 1.04e-04 | 82 | 42 | 4 | MP:0020914 | |
| MousePheno | decreased susceptibility to infection | 1.05e-04 | 255 | 42 | 6 | MP:0002409 | |
| MousePheno | abnormal susceptibility to infection | IL12B CEACAM5 CLEC4A CFTR CEACAM7 CEACAM6 TNFRSF1B ZFYVE1 CEACAM1 | 1.39e-04 | 672 | 42 | 9 | MP:0001793 |
| MousePheno | abnormal incidence of induced tumors | 1.41e-04 | 269 | 42 | 6 | MP:0013151 | |
| MousePheno | abnormal respiratory quotient | 1.84e-04 | 178 | 42 | 5 | MP:0004129 | |
| MousePheno | increased body size | 1.94e-04 | 409 | 42 | 7 | MP:0001264 | |
| MousePheno | abnormal response to infection | IL12B CEACAM5 CLEC4A CFTR CEACAM7 CEACAM6 TNFRSF1B ZFYVE1 CEACAM1 | 2.19e-04 | 714 | 42 | 9 | MP:0005025 |
| MousePheno | increased total body fat amount | 2.42e-04 | 424 | 42 | 7 | MP:0010024 | |
| MousePheno | abnormal response to antigen | IL12B CEACAM5 CLEC4A CFTR CEACAM7 CEACAM6 TNFRSF1B ZFYVE1 CEACAM1 | 2.48e-04 | 726 | 42 | 9 | MP:0020000 |
| MousePheno | increased circulating hormone level | 2.77e-04 | 578 | 42 | 8 | MP:0014456 | |
| MousePheno | abnormal oxygen consumption | 2.81e-04 | 195 | 42 | 5 | MP:0005288 | |
| MousePheno | insulin resistance | 2.94e-04 | 197 | 42 | 5 | MP:0005331 | |
| MousePheno | abnormal lean body mass | GHR STIM1 CEACAM5 THSD7A SWT1 CEACAM7 CEACAM8 CEACAM6 CEACAM1 | 3.13e-04 | 749 | 42 | 9 | MP:0003959 |
| MousePheno | decreased susceptibility to autoimmune diabetes | 3.28e-04 | 45 | 42 | 3 | MP:0004804 | |
| MousePheno | abnormal gas homeostasis | STIM1 CEACAM5 CEACAM7 CEACAM8 CEACAM6 TNFRSF1B CEACAM1 SLC5A3 | 3.56e-04 | 600 | 42 | 8 | MP:0003948 |
| MousePheno | abnormal eating behavior | 3.72e-04 | 604 | 42 | 8 | MP:0001431 | |
| MousePheno | abnormal circulating hormone level | GHR STIM1 MGAM SLC5A10 CEACAM5 CEACAM7 CEACAM8 CEACAM6 CEACAM1 SLC5A2 | 4.13e-04 | 954 | 42 | 10 | MP:0005418 |
| MousePheno | increased hormone level | 5.53e-04 | 641 | 42 | 8 | MP:0014454 | |
| MousePheno | increased triglyceride level | 6.14e-04 | 354 | 42 | 6 | MP:0005317 | |
| MousePheno | abnormal physiological response to xenobiotic | 6.85e-04 | 662 | 42 | 8 | MP:0008872 | |
| MousePheno | abnormal skeletal muscle morphology | 7.18e-04 | 508 | 42 | 7 | MP:0000759 | |
| MousePheno | abnormal cytokine secretion | 7.26e-04 | 668 | 42 | 8 | MP:0003009 | |
| MousePheno | abnormal circulating triglyceride level | 7.87e-04 | 516 | 42 | 7 | MP:0011969 | |
| MousePheno | increased circulating creatine kinase level | 8.04e-04 | 61 | 42 | 3 | MP:0010090 | |
| MousePheno | increased incidence of tumors by chemical induction | 8.25e-04 | 141 | 42 | 4 | MP:0004499 | |
| MousePheno | increased creatine kinase level | 8.43e-04 | 62 | 42 | 3 | MP:0020280 | |
| MousePheno | abnormal consumption behavior | 9.41e-04 | 695 | 42 | 8 | MP:0002069 | |
| MousePheno | abnormal circulating creatine kinase level | 9.68e-04 | 65 | 42 | 3 | MP:0010089 | |
| MousePheno | abnormal creatine kinase level | 1.01e-03 | 66 | 42 | 3 | MP:0020279 | |
| MousePheno | abnormal hormone level | GHR STIM1 MGAM SLC5A10 CEACAM5 CEACAM7 CEACAM8 CEACAM6 CEACAM1 SLC5A2 | 1.04e-03 | 1073 | 42 | 10 | MP:0003953 |
| MousePheno | abnormal adipose tissue amount | GHR STIM1 CEACAM5 SWT1 CEACAM7 CEACAM8 CEACAM6 ZDHHC13 CEACAM1 SLC5A2 | 1.07e-03 | 1077 | 42 | 10 | MP:0005452 |
| MousePheno | decreased interferon-gamma secretion | 1.12e-03 | 153 | 42 | 4 | MP:0008567 | |
| MousePheno | abnormal large intestine morphology | 1.35e-03 | 276 | 42 | 5 | MP:0000489 | |
| MousePheno | abnormal susceptibility to viral infection | 1.42e-03 | 279 | 42 | 5 | MP:0020185 | |
| MousePheno | increased incidence of induced tumors | 1.76e-03 | 173 | 42 | 4 | MP:0002021 | |
| MousePheno | abnormal adipose tissue morphology | GHR STIM1 SLC5A10 CEACAM5 SWT1 CEACAM7 CEACAM8 CEACAM6 ZDHHC13 CEACAM1 SLC5A2 | 1.79e-03 | 1361 | 42 | 11 | MP:0000003 |
| MousePheno | decreased susceptibility to autoimmune disorder | 2.03e-03 | 180 | 42 | 4 | MP:0005351 | |
| MousePheno | adipose tissue phenotype | GHR STIM1 SLC5A10 CEACAM5 SWT1 CEACAM7 CEACAM8 CEACAM6 ZDHHC13 CEACAM1 SLC5A2 | 2.04e-03 | 1383 | 42 | 11 | MP:0005375 |
| MousePheno | abnormal susceptibility to autoimmune disorder | 2.16e-03 | 307 | 42 | 5 | MP:0002425 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 2.29e-03 | 186 | 42 | 4 | MP:0020912 | |
| MousePheno | abnormal energy expenditure | 2.35e-03 | 313 | 42 | 5 | MP:0005450 | |
| MousePheno | abnormal tumor incidence | 2.60e-03 | 635 | 42 | 7 | MP:0002019 | |
| MousePheno | abnormal wound healing | 2.62e-03 | 193 | 42 | 4 | MP:0005023 | |
| MousePheno | abnormal energy homeostasis | 2.66e-03 | 322 | 42 | 5 | MP:0005448 | |
| MousePheno | abnormal triglyceride level | 2.70e-03 | 639 | 42 | 7 | MP:0000187 | |
| MousePheno | abnormal tumor susceptibility | 2.97e-03 | 650 | 42 | 7 | MP:0002166 | |
| Domain | NA_SOLUT_SYMP_2 | 3.27e-08 | 12 | 55 | 4 | PS00457 | |
| Domain | SSF | 3.27e-08 | 12 | 55 | 4 | PF00474 | |
| Domain | Na/solute_symporter | 3.27e-08 | 12 | 55 | 4 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 3.27e-08 | 12 | 55 | 4 | PS50283 | |
| Domain | Aspartic_peptidase_N | 8.39e-07 | 7 | 55 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 8.39e-07 | 7 | 55 | 3 | PF07966 | |
| Domain | Na/solute_symporter_CS | 1.34e-06 | 8 | 55 | 3 | IPR018212 | |
| Domain | Aspartic_peptidase_A1 | 2.86e-06 | 10 | 55 | 3 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 2.86e-06 | 10 | 55 | 3 | IPR033121 | |
| Domain | Asp | 2.86e-06 | 10 | 55 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 2.86e-06 | 10 | 55 | 3 | PS51767 | |
| Domain | NA_SOLUT_SYMP_1 | 3.92e-06 | 11 | 55 | 3 | PS00456 | |
| Domain | - | 5.22e-06 | 12 | 55 | 3 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 5.22e-06 | 12 | 55 | 3 | PS00141 | |
| Domain | Aspartic_peptidase_AS | 6.77e-06 | 13 | 55 | 3 | IPR001969 | |
| Domain | Peptidase_aspartic_dom | 1.60e-05 | 17 | 55 | 3 | IPR021109 | |
| Domain | NtCtMGAM_N | 5.09e-05 | 4 | 55 | 2 | PF16863 | |
| Domain | Gal_mutarotase_N | 5.09e-05 | 4 | 55 | 2 | IPR031727 | |
| Domain | Ig_2 | 6.30e-05 | 73 | 55 | 4 | PF13895 | |
| Domain | Glyco_hydro_31_AS | 1.27e-04 | 6 | 55 | 2 | IPR030458 | |
| Domain | Glyco_hydro_31 | 1.77e-04 | 7 | 55 | 2 | PF01055 | |
| Domain | Glyco_hydro_31 | 1.77e-04 | 7 | 55 | 2 | IPR000322 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 1.77e-04 | 7 | 55 | 2 | PS00129 | |
| Domain | V-set | 2.05e-04 | 184 | 55 | 5 | PF07686 | |
| Domain | Trefoil | 2.36e-04 | 8 | 55 | 2 | PF00088 | |
| Domain | Ig_I-set | 2.38e-04 | 190 | 55 | 5 | IPR013098 | |
| Domain | I-set | 2.38e-04 | 190 | 55 | 5 | PF07679 | |
| Domain | Ig_V-set | 2.95e-04 | 199 | 55 | 5 | IPR013106 | |
| Domain | P_TREFOIL_2 | 3.02e-04 | 9 | 55 | 2 | PS51448 | |
| Domain | PD | 3.02e-04 | 9 | 55 | 2 | SM00018 | |
| Domain | - | 4.60e-04 | 11 | 55 | 2 | 4.10.110.10 | |
| Domain | Glycoside_hydrolase_SF | 5.10e-04 | 53 | 55 | 3 | IPR017853 | |
| Domain | P_trefoil_dom | 5.51e-04 | 12 | 55 | 2 | IPR000519 | |
| Domain | IGc2 | 6.30e-04 | 235 | 55 | 5 | SM00408 | |
| Domain | Ig_sub2 | 6.30e-04 | 235 | 55 | 5 | IPR003598 | |
| Domain | - | 6.74e-04 | 663 | 55 | 8 | 2.60.40.10 | |
| Domain | Ig-like_fold | 1.01e-03 | 706 | 55 | 8 | IPR013783 | |
| Domain | Gal_mutarotase_SF_dom | 1.13e-03 | 17 | 55 | 2 | IPR011013 | |
| Domain | ig | 2.36e-03 | 190 | 55 | 4 | PF00047 | |
| Domain | Immunoglobulin | 2.36e-03 | 190 | 55 | 4 | IPR013151 | |
| Domain | SR | 2.45e-03 | 25 | 55 | 2 | SM00202 | |
| Domain | - | 2.45e-03 | 25 | 55 | 2 | 3.10.250.10 | |
| Domain | SRCR_1 | 2.64e-03 | 26 | 55 | 2 | PS00420 | |
| Domain | SRCR-like_dom | 2.64e-03 | 26 | 55 | 2 | IPR017448 | |
| Domain | SRCR_2 | 2.64e-03 | 26 | 55 | 2 | PS50287 | |
| Domain | SRCR | 2.85e-03 | 27 | 55 | 2 | IPR001190 | |
| Domain | IG_LIKE | 3.12e-03 | 491 | 55 | 6 | PS50835 | |
| Domain | Ig-like_dom | 3.51e-03 | 503 | 55 | 6 | IPR007110 | |
| Domain | - | 6.18e-03 | 40 | 55 | 2 | 3.40.630.30 | |
| Domain | Acyl_CoA_acyltransferase | 7.77e-03 | 45 | 55 | 2 | IPR016181 | |
| Domain | IG | 7.84e-03 | 421 | 55 | 5 | SM00409 | |
| Domain | Ig_sub | 7.84e-03 | 421 | 55 | 5 | IPR003599 | |
| Domain | BTB | 1.17e-02 | 160 | 55 | 3 | PS50097 | |
| Pathway | REACTOME_FIBRONECTIN_MATRIX_FORMATION | 6.04e-07 | 6 | 45 | 3 | M26970 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 4.93e-06 | 11 | 45 | 3 | M39726 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 1.51e-05 | 99 | 45 | 5 | MM14624 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 1.16e-04 | 30 | 45 | 3 | M27566 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.41e-04 | 158 | 45 | 5 | MM14812 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 3.54e-04 | 9 | 45 | 2 | M47622 | |
| Pubmed | 6.48e-12 | 4 | 57 | 4 | 26483485 | ||
| Pubmed | 6.48e-12 | 4 | 57 | 4 | 10436421 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 28567513 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 8207827 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 11994468 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 1.96e-11 | 14 | 57 | 5 | 27161904 | |
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 20381490 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 23070997 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 10491101 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 22159884 | ||
| Pubmed | 2.93e-11 | 15 | 57 | 5 | 24948196 | ||
| Pubmed | 2.93e-11 | 15 | 57 | 5 | 20410265 | ||
| Pubmed | 2.93e-11 | 15 | 57 | 5 | 26586918 | ||
| Pubmed | 4.26e-11 | 16 | 57 | 5 | 25085348 | ||
| Pubmed | Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. | 4.26e-11 | 16 | 57 | 5 | 11284729 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 3017318 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 4.17e-09 | 3 | 57 | 3 | 21989121 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 9855083 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 9797498 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 2478370 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 4.17e-09 | 3 | 57 | 3 | 10675278 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 7926498 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 3780036 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 9561228 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 21455714 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 19800305 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 2901984 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 4.17e-09 | 3 | 57 | 3 | 3839486 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 24170207 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 3467902 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 4586732 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 4.17e-09 | 3 | 57 | 3 | 3014868 | |
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 4.17e-09 | 3 | 57 | 3 | 2892778 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 24383519 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 4.17e-09 | 3 | 57 | 3 | 2831884 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 4.17e-09 | 3 | 57 | 3 | 2799289 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 4.17e-09 | 3 | 57 | 3 | 1968039 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 2032552 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 8053437 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 25409014 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 1812762 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 7923573 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 4.17e-09 | 3 | 57 | 3 | 2566575 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 4.17e-09 | 3 | 57 | 3 | 12588289 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 4.17e-09 | 3 | 57 | 3 | 2229438 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 4.17e-09 | 3 | 57 | 3 | 19890696 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 17167768 | ||
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 4.17e-09 | 3 | 57 | 3 | 23897256 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 31171910 | ||
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 4.17e-09 | 3 | 57 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 4.17e-09 | 3 | 57 | 3 | 1956484 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 8540382 | ||
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 4.17e-09 | 3 | 57 | 3 | 8244094 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 21407214 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 4.17e-09 | 3 | 57 | 3 | 20981206 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 6774973 | ||
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 4.17e-09 | 3 | 57 | 3 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 4.17e-09 | 3 | 57 | 3 | 21970995 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 4.17e-09 | 3 | 57 | 3 | 22304859 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 24004680 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 8038355 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 20428942 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 4.17e-09 | 3 | 57 | 3 | 2227273 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 9525001 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 7886402 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 23034090 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 24125879 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 17379991 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 4.17e-09 | 3 | 57 | 3 | 3554488 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 21547904 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 23521833 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 4.58e-09 | 13 | 57 | 4 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 4.58e-09 | 13 | 57 | 4 | 1985902 | |
| Pubmed | 4.58e-09 | 13 | 57 | 4 | 10964771 | ||
| Pubmed | 4.58e-09 | 13 | 57 | 4 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 4.58e-09 | 13 | 57 | 4 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 4.58e-09 | 13 | 57 | 4 | 16638824 | |
| Pubmed | 4.58e-09 | 13 | 57 | 4 | 20044046 | ||
| Pubmed | 4.58e-09 | 13 | 57 | 4 | 32150576 | ||
| Pubmed | 4.58e-09 | 13 | 57 | 4 | 22469976 | ||
| Pubmed | 4.58e-09 | 13 | 57 | 4 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 4.58e-09 | 13 | 57 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 4.58e-09 | 13 | 57 | 4 | 28035001 | |
| Pubmed | 4.58e-09 | 13 | 57 | 4 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 4.58e-09 | 13 | 57 | 4 | 12832451 | |
| Pubmed | 4.58e-09 | 13 | 57 | 4 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 4.58e-09 | 13 | 57 | 4 | 15316023 | |
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 4.58e-09 | 13 | 57 | 4 | 21670291 | |
| Pubmed | 4.58e-09 | 13 | 57 | 4 | 22162753 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 4.58e-09 | 13 | 57 | 4 | 23935487 | |
| Pubmed | 4.58e-09 | 13 | 57 | 4 | 2702644 | ||
| Pubmed | 4.58e-09 | 13 | 57 | 4 | 8380065 | ||
| Interaction | CEACAM1 interactions | 2.71e-09 | 21 | 56 | 5 | int:CEACAM1 | |
| Interaction | CEACAM6 interactions | 3.61e-08 | 34 | 56 | 5 | int:CEACAM6 | |
| Interaction | CEACAM7 interactions | 7.06e-07 | 7 | 56 | 3 | int:CEACAM7 | |
| Interaction | CEACAM5 interactions | 7.24e-06 | 14 | 56 | 3 | int:CEACAM5 | |
| Interaction | ATP2B4 interactions | 1.70e-05 | 196 | 56 | 6 | int:ATP2B4 | |
| Interaction | CD209 interactions | 3.46e-05 | 23 | 56 | 3 | int:CD209 | |
| Cytoband | 1q25 | 4.62e-06 | 26 | 57 | 3 | 1q25 | |
| Cytoband | 19q13.2 | 5.35e-05 | 164 | 57 | 4 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 9.05e-04 | 345 | 57 | 4 | chr11q12 | |
| Cytoband | 11q12.2 | 1.09e-03 | 39 | 57 | 2 | 11q12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 1.20e-03 | 167 | 57 | 3 | chr1q25 | |
| Cytoband | 1q41 | 3.09e-03 | 66 | 57 | 2 | 1q41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 3.55e-03 | 1192 | 57 | 6 | chr19q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q41 | 6.03e-03 | 93 | 57 | 2 | chr1q41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 6.64e-03 | 307 | 57 | 3 | chr17q25 | |
| Cytoband | 17q25.3 | 7.07e-03 | 101 | 57 | 2 | 17q25.3 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 1.29e-09 | 24 | 38 | 5 | 906 | |
| GeneFamily | Immunoglobulin like domain containing | 2.84e-06 | 193 | 38 | 6 | 594 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.21e-05 | 163 | 38 | 5 | 590 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.58e-04 | 394 | 38 | 6 | 471 | |
| GeneFamily | Dyneins, axonemal | 5.73e-04 | 17 | 38 | 2 | 536 | |
| GeneFamily | Mitochondrial complex IV: cytochrome c oxidase subunits | 7.19e-04 | 19 | 38 | 2 | 643 | |
| GeneFamily | Solute carriers | 9.22e-03 | 395 | 38 | 4 | 752 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 6.25e-07 | 75 | 57 | 5 | MM605 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 6.90e-07 | 32 | 57 | 4 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.00e-06 | 35 | 57 | 4 | MM757 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 3.64e-06 | 48 | 57 | 4 | MM531 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 4.95e-06 | 201 | 57 | 6 | MM1006 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN | 1.02e-05 | 132 | 57 | 5 | M15410 | |
| Coexpression | BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE | 1.56e-05 | 69 | 57 | 4 | M2533 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 3.91e-05 | 87 | 57 | 4 | MM851 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 4.33e-05 | 436 | 57 | 7 | MM1326 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 4.93e-05 | 302 | 57 | 6 | MM16604 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_BCELL_UP | 7.46e-05 | 200 | 57 | 5 | M5515 | |
| Coexpression | CROMER_TUMORIGENESIS_DN | 1.67e-04 | 49 | 57 | 3 | M16948 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.75e-04 | 128 | 57 | 4 | MM1000 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | 1.91e-04 | 741 | 57 | 8 | MM1037 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | 2.00e-04 | 746 | 57 | 8 | M40863 | |
| Coexpression | DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP | 2.11e-04 | 53 | 57 | 3 | M2546 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 2.15e-04 | 135 | 57 | 4 | MM965 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.00e-07 | 179 | 56 | 6 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-07 | 180 | 56 | 6 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-07 | 180 | 56 | 6 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.18e-07 | 184 | 56 | 6 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-07 | 185 | 56 | 6 | f3fbc3096f85397a959cee17c3c4fcf2d511f3d5 | |
| ToppCell | (5)_Epi_upper|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.52e-07 | 192 | 56 | 6 | 0c8f73cfd24531a040544df39f28626433aaa651 | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_upper|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.52e-07 | 192 | 56 | 6 | 69b6b3ceaad6432c46d1bc2a00b8389069a8876e | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.66e-07 | 195 | 56 | 6 | fb3dc2c8fd125f23d0c3aa211520778aac8d6dda | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Neutrophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.71e-07 | 196 | 56 | 6 | 36c01e0feea33448222010c21442b9fac671bd7d | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.88e-07 | 199 | 56 | 6 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.88e-07 | 199 | 56 | 6 | caf2e050b21e7a16ce4e51b3f135debd06810231 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.57e-07 | 131 | 56 | 5 | fdec4e31ffeb02615ccb7097758a8218dd1f8c1c | |
| ToppCell | COVID-19_Mild-Myeloid_G|COVID-19_Mild / Disease group, lineage and cell class | 9.79e-07 | 142 | 56 | 5 | c8aeb747ed836197265d269aa131fae172b45aec | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-06 | 143 | 56 | 5 | 974260c25dad599eea83a33e83117f7307b92a42 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-06 | 181 | 56 | 5 | 1c04e53f46992a0aea9d3eee985681ec4e71f80d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-06 | 181 | 56 | 5 | 83adf61f44cebe9e75de175c5dc39237fbf9ed24 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 183 | 56 | 5 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Neutrophil|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.59e-06 | 185 | 56 | 5 | 655fb705d7a029844ecb4f6a53e948e37ee81006 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Myelocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.68e-06 | 186 | 56 | 5 | 53b4ce33ae6fa32f1b56cbc62b1d7915e935afc9 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.09e-06 | 190 | 56 | 5 | cb62ece5929896dfba30a4f563c6ba5a5712b71e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.09e-06 | 190 | 56 | 5 | fedd266198d294d8da8c9e217e5e0cb8b2e1b566 | |
| ToppCell | COVID-19_Severe-Myeloid_G|COVID-19_Severe / Disease group, lineage and cell class | 4.09e-06 | 190 | 56 | 5 | 8a81cb90273c361e9fdfaa0a31806da253fa1388 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.19e-06 | 191 | 56 | 5 | fbd8d337b4444fba8527a614e4a8bfb516ce0f66 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-CX3CR1+_Mac|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.41e-06 | 193 | 56 | 5 | afc20433b5abc9b430751a2aa8d93b0fd136a888 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.87e-06 | 197 | 56 | 5 | 8dd10962b6ba587512b2e68c762ade68c751cbc8 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.00e-06 | 198 | 56 | 5 | 82f6ac18c3a6487f03579b5c247844f1c115c2be | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.00e-06 | 198 | 56 | 5 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.00e-06 | 198 | 56 | 5 | f870e398e996c1f28c8462d87b18f71b20c71011 | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.00e-06 | 198 | 56 | 5 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.00e-06 | 198 | 56 | 5 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.12e-06 | 199 | 56 | 5 | 156354b799346d441dde42dbba09d7bde89ad460 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.25e-06 | 200 | 56 | 5 | cad2d972aa6ea0cc9ebe5ec60fda6e306e9ee2b2 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 56 | 5 | 133853d0f55c63ebe94dd54151f9f1f90650a0d8 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.25e-06 | 200 | 56 | 5 | 3f29823952a4303451997dd5177a51179bd20540 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 56 | 5 | 8f811ddd84c037a250d124496b0fbb2e4717011c | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.25e-06 | 200 | 56 | 5 | b2fa6e44ace5897766792ed97ffafc11555175e7 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-05 | 108 | 56 | 4 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-05 | 108 | 56 | 4 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | COVID-19_Mild-Neutrophil|COVID-19_Mild / Disease condition and Cell class | 1.69e-05 | 122 | 56 | 4 | bc4346f4caaed153583b0fe8521b45437f5c3049 | |
| ToppCell | COVID-19_Mild-Neutrophil-|COVID-19_Mild / Disease condition and Cell class | 1.69e-05 | 122 | 56 | 4 | 6ce3e9e2868d6cdc4ed90b90b2541b8f51270cac | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.24e-05 | 131 | 56 | 4 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Lpl-Cadm2_(Layer_2/3,_Cadm2+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.04e-05 | 48 | 56 | 3 | bbfc33299ea8e6895dd4d21a7dd38bec33563127 | |
| ToppCell | Control-Myeloid-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.12e-05 | 153 | 56 | 4 | c33d63b2d1a220bc428e776b157b23faa43ea8ca | |
| ToppCell | Control-Myeloid-Neutrophils-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.12e-05 | 153 | 56 | 4 | e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.22e-05 | 154 | 56 | 4 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.22e-05 | 154 | 56 | 4 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.22e-05 | 154 | 56 | 4 | b5604c0b0b9b283352a3f612f40883b9123475d1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.22e-05 | 154 | 56 | 4 | 160b170a3ade8b246843c9854af332475c047ba0 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.33e-05 | 155 | 56 | 4 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Cxcl14_(dSPN,_lateral_striatum)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.94e-05 | 60 | 56 | 3 | 64d4de1de20d07c5f2e20b76854311a31718faa4 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Cxcl14_(dSPN,_lateral_striatum)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.94e-05 | 60 | 56 | 3 | b3941f8c3cf2365c5bf79961f62c9c0c7405a67b | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.06e-05 | 169 | 56 | 4 | 4a5d023ffcf83312d29b1d215eb6b744ef1a0777 | |
| ToppCell | facs-Heart-LA-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 169 | 56 | 4 | 421fb287c7e439d1870b7950c5e3ca34106e014a | |
| ToppCell | facs-Heart-LA-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 169 | 56 | 4 | 383639ec4f9d0c6255e0881edca15cdd1980a37c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.06e-05 | 169 | 56 | 4 | 1dfaf9a6b433a5ee86a11962af188978c2543278 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.06e-05 | 169 | 56 | 4 | f33f4a0baad1b3cb5be61dfc7b00c7a3845f7120 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.06e-05 | 169 | 56 | 4 | 3e267ec9f884df326315500dfd751b04a3dd91bd | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-05 | 171 | 56 | 4 | 0de81d12a8000f2c59cdb214e67dc526d18098fe | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-05 | 171 | 56 | 4 | 0597339618fb4d416d55c538eceb353218a55002 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-05 | 171 | 56 | 4 | 317b70d72a4ca5336cfb6a49dc57f8e2a8a1c736 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Squamous|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.78e-05 | 174 | 56 | 4 | 0a4721248ec89bc98ebe119de6e19fbfca8b5098 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.94e-05 | 175 | 56 | 4 | 8252ddc2ca95071381f0354aefb70c4714828491 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.94e-05 | 175 | 56 | 4 | 8ccf60fc469059d7aaf4e6ce54159db2962e0060 | |
| ToppCell | (00)_Basal-(2)_48hpi|(00)_Basal / shred by cell type and Timepoint | 7.09e-05 | 176 | 56 | 4 | 0f6770296d7fa453ffbf6ca6d5fdebc888f6eb60 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 176 | 56 | 4 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.41e-05 | 178 | 56 | 4 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.74e-05 | 180 | 56 | 4 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.74e-05 | 180 | 56 | 4 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.74e-05 | 180 | 56 | 4 | 8ba9bba0c9fecf184a4332ba4585fb2439f68cd3 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-05 | 180 | 56 | 4 | cd743f81838ba210e5bb63fe0870918d7d2b0112 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.74e-05 | 180 | 56 | 4 | d1beaf1f106c7efaeaf61f29742d0a7310a83916 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 7.74e-05 | 180 | 56 | 4 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.74e-05 | 180 | 56 | 4 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.74e-05 | 180 | 56 | 4 | 156b988b71f6dcf3117c1e5f4625632cb97e54f2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-05 | 181 | 56 | 4 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-05 | 181 | 56 | 4 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.90e-05 | 181 | 56 | 4 | bad77767e64cc093a827a6b0f3f401f3f108e457 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.07e-05 | 182 | 56 | 4 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.07e-05 | 182 | 56 | 4 | e98ca9df33a1a81fc83ecf73d5141a14f2bc985c | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.07e-05 | 182 | 56 | 4 | 1932d77491d6d46278f01fd70eb469ef1b356619 | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.25e-05 | 183 | 56 | 4 | cfbf8539104cef9ca830ad4f6bb278746f7078f7 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 8.25e-05 | 183 | 56 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.25e-05 | 183 | 56 | 4 | 9ca4954faaba50466c35121d6765895e955178aa | |
| ToppCell | cellseq2-Immune-Hematopoietic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.25e-05 | 183 | 56 | 4 | 324ec4374b552da7ce03809945b3a0798342d4ba | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 8.42e-05 | 184 | 56 | 4 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.42e-05 | 184 | 56 | 4 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Myelocyte-like|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.60e-05 | 185 | 56 | 4 | 92b9ec18ff7c53a52b87e2c2012d0b719a7ad20a | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.60e-05 | 185 | 56 | 4 | 42690b95e2e7d56c822211bb1150acb787cfe2e8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.60e-05 | 185 | 56 | 4 | d1cfca6e85fa767253de7e8a14621989b816635f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-05 | 186 | 56 | 4 | fa5f602f01de5beec529d9f5208172b2914a952d | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 8.96e-05 | 187 | 56 | 4 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | facs-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 187 | 56 | 4 | 208686e6ebc9f3a774bcbe89274457ac9449f90e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-05 | 188 | 56 | 4 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 9.15e-05 | 188 | 56 | 4 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-05 | 188 | 56 | 4 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.15e-05 | 188 | 56 | 4 | 6b185d0aaeea64f9ae584a9bcb9741658bb1c7bd | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV5/7_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.34e-05 | 189 | 56 | 4 | c8cfdc928ec29262f94ef3362a3f854716792a79 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.72e-05 | 50 | 38 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_30_PDAC_CLASSICAL | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.71e-04 | 49 | 38 | 3 | GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_T_REG | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.12e-04 | 50 | 38 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.12e-04 | 50 | 38 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_40_PDAC_RELATED | |
| Computational | Genes in the cancer module 103. | 7.85e-04 | 12 | 38 | 2 | MODULE_103 | |
| Drug | AC1L1IPV | 6.72e-08 | 43 | 56 | 5 | CID000004683 | |
| Drug | furosemide | 4.52e-06 | 272 | 56 | 7 | CID000003440 | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; PC3; HT_HG-U133A | 8.07e-06 | 194 | 56 | 6 | 3816_UP | |
| Drug | N(3)ATP | 1.78e-05 | 3 | 56 | 2 | CID000133414 | |
| Drug | Phosphodiesterase Inhibitors | 1.78e-05 | 3 | 56 | 2 | ctd:D010726 | |
| Drug | 2,4-dichlorophenoxyacetic acid | 1.83e-05 | 132 | 56 | 5 | CID000001486 | |
| Drug | AC1L9JSY | 3.55e-05 | 4 | 56 | 2 | CID000446552 | |
| Disease | 1,5 anhydroglucitol measurement | 2.30e-07 | 29 | 54 | 4 | EFO_0008009 | |
| Disease | Early Pregnancy Loss | 4.83e-05 | 109 | 54 | 4 | C3830362 | |
| Disease | Miscarriage | 4.83e-05 | 109 | 54 | 4 | C4552766 | |
| Disease | Spontaneous abortion | 4.83e-05 | 109 | 54 | 4 | C0000786 | |
| Disease | Abortion, Tubal | 4.83e-05 | 109 | 54 | 4 | C0000822 | |
| Disease | Ankylosing spondylitis | 1.79e-04 | 11 | 54 | 2 | C0038013 | |
| Disease | idiopathic dilated cardiomyopathy | 1.84e-04 | 60 | 54 | 3 | EFO_0009094 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 5.51e-04 | 19 | 54 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | serum carcinoembryonic antigen measurement | 6.12e-04 | 20 | 54 | 2 | EFO_0005760 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 1.29e-03 | 29 | 54 | 2 | DOID:11984 (implicated_via_orthology) | |
| Disease | anxiety disorder | 1.38e-03 | 30 | 54 | 2 | EFO_0006788 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DTNGEVLWVWCYPST | 21 | Q6NSW5 | |
| QRLYTWTQAVVGTWP | 316 | Q400G9 | |
| TRQFPWAVQTWYDSL | 351 | P13569 | |
| TCEPETQDATYLWWV | 166 | P06731 | |
| FTCEPEAQNTTYLWW | 521 | P06731 | |
| TCEPETQNTTYLWWV | 166 | P31997 | |
| LTCQPETQNTTYLWW | 166 | Q14002 | |
| TYLWWVNNQSLLVSP | 176 | Q14002 | |
| WYNVENWRTAVTSPD | 196 | Q9Y485 | |
| VTWTYVATQVGIEWN | 51 | P24311 | |
| CVTWTTRDGVWEAYQ | 316 | Q15818 | |
| LNWVPVTVEGYWQIT | 241 | P0DJD9 | |
| TLSCYSEVWVVPWLQ | 121 | O76096 | |
| VSWSLVYLPTIQSCW | 476 | Q08380 | |
| VFPDYTNPVCTEWWT | 446 | Q2M2H8 | |
| TNPVCTEWWTDQVAK | 451 | Q2M2H8 | |
| QVYTSPAAVAVWEWQ | 11 | Q86UW9 | |
| QVYWPTVLTTITSWI | 271 | Q9UN88 | |
| TCEPEVQNTTYLWWV | 166 | P40199 | |
| YTNPNCAVWWTKEFE | 501 | O43451 | |
| PDTWCFIDWTTNVTA | 166 | P35408 | |
| SCEWHQWTCYPQNLV | 286 | Q969I3 | |
| YTVNEPWLFSLAWCS | 426 | Q6W3E5 | |
| QVEVSWEYPDTWSTP | 251 | P29460 | |
| AWYLIAWENSSVPVA | 106 | Q86UY6 | |
| LNWVPVTVEGYWQIT | 241 | P0DJD8 | |
| SISVYTNRIQPWSWQ | 1066 | Q7Z442 | |
| VNCCTIDWFVQWPRE | 2596 | Q9C0G6 | |
| CVWRYNSSVNEWAEV | 351 | Q9UJP4 | |
| YPAQVALTCTQIWWT | 1691 | Q9UFH2 | |
| TQEWTQEWKECPDYV | 91 | P10912 | |
| TCEPETQDTTYLWWI | 166 | P13688 | |
| VWYEWAVTAPVCSAI | 611 | O14744 | |
| WPECTCTNRDWYEQV | 106 | Q92796 | |
| PFTTVWNANTQWCLE | 31 | Q12794 | |
| DTNGEVLWVWCYPST | 21 | Q8TCE6 | |
| WQQVFTSPYLDWTIE | 216 | Q9Y597 | |
| SNWEQILYVTEPEAW | 211 | Q13895 | |
| YQSLCPTSWVTDWDE | 61 | P14854 | |
| PSYLEWTAQVQSQAW | 41 | Q9BTA0 | |
| LNWVPVTVEGYWQIT | 241 | P0DJD7 | |
| QPWTQCEYKIYTWNS | 4231 | O75445 | |
| QTPFYTVENSQWSLW | 36 | A5PLK6 | |
| QYLWVTEPWSICKVT | 1096 | Q9UPZ6 | |
| ASVWYWCADQVIVQR | 271 | P53794 | |
| PSLWYWCTDQVIVQR | 281 | Q8WWX8 | |
| NTDPECYWLTNWIET | 136 | P43490 | |
| NWIETILVQSWYPIT | 146 | P43490 | |
| WSILESVWITIYQNS | 756 | Q5T5J6 | |
| NWTVDEVVQWLITYV | 131 | Q13586 | |
| WQWVDQTPYNESSTF | 176 | Q9UMR7 | |
| EPITRWGEYWCEVTV | 211 | Q9BYD2 | |
| LWTYLNQIVACSPWV | 506 | Q8IUH4 | |
| VSGWYWCSDQVIVQR | 286 | P31639 | |
| WYWCTDQVIVQRSLS | 276 | A0PJK1 | |
| LWEVQCESPTFTVAW | 301 | Q96J01 | |
| ASVDSWPWQVSIQYD | 211 | Q9NRS4 | |
| AVTSWLTDQIAPAYW | 581 | Q9HBF4 | |
| STYTQLWNWVPECLS | 81 | P20333 | |
| IWEVIEYNPSQCLDW | 2631 | Q70CQ2 | |
| RVDPWECYQDTWQTT | 81 | Q9BZQ4 |